BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1478232)

  • 1. Flow-cytometric deoxyribonucleic acid analysis of the human bladder cancers with reference to histopathological findings.
    Hamano K; Kinjo M; Kumazawa J
    Eur Urol; 1992; 22(2):153-7. PubMed ID: 1478232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-Flow cytometric analysis of bladder TCC using paraffin-embedded tissues.
    Wu L; Lochhead A; Yang J; Ow KT; Russell PJ
    Urol Int; 1998 Aug; 60(4):208-15. PubMed ID: 9701732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder.
    Shariat SF; Weizer AZ; Green A; Laucirica R; Frolov A; Wheeler TM; Lerner SP
    Urology; 2000 Nov; 56(5):735-40. PubMed ID: 11068290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative flow cytometric deoxyribonucleic acid studies on exophytic tumor and random mucosal biopsies in untreated carcinoma of the bladder.
    Norming U; Nyman CR; Tribukait B
    J Urol; 1989 Dec; 142(6):1442-7. PubMed ID: 2585616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral heterogeneity in DNA ploidy of bladder carcinomas.
    Sasaki K; Hamano K; Kinjo M; Hara S
    Oncology; 1992; 49(3):219-22. PubMed ID: 1495749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas.
    van Velthoven R; Petein M; Oosterlinck WJ; Zandona C; Zlotta A; Van der Meijden AP; Pasteels JL; Roels H; Schulman C; Kiss R
    Hum Pathol; 1995 Jan; 26(1):3-11. PubMed ID: 7821913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of mucosal aneuploidy in stage Ta/T1 grade 3 carcinoma of the bladder.
    Norming U; Tribukait B; Nyman CR; Nilsson B; Wang N
    J Urol; 1992 Nov; 148(5):1420-6; discussion 1426-7. PubMed ID: 1433541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ploidy disturbance of normal-appearing bladder mucosa in patients with urothelial cancer: relationship to morphology.
    Farsund T; Laerum OD; Høstmark J
    J Urol; 1983 Dec; 130(6):1076-82. PubMed ID: 6644885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric analysis of DNA content in human bladder tumors and irrigation fluids.
    Chin JL; Huben RP; Nava E; Rustum YM; Greco JM; Pontes JE; Frankfurt OS
    Cancer; 1985 Oct; 56(7):1677-81. PubMed ID: 4027899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of flow cytometric deoxyribonucleic acid analysis for patients with superficial bladder cancers: a long-term follow-up study.
    Tachibana M; Miyakawa A; Miyakawa M; Saito S; Nakamura K; Baba S; Murai M
    Cancer Detect Prev; 1999; 23(2):155-62. PubMed ID: 10101597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric DNA/cytokeratin analysis of bladder lavage: methodical aspects and clinical implications.
    Liedl T
    Urol Int; 1995; 54(1):22-47. PubMed ID: 7770998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Image cytometric DNA analysis in bladder tumors].
    Yamamoto S; Akiyama A; Ito T; Miki M; Furusato M; Aizawa S
    Nihon Hinyokika Gakkai Zasshi; 1996 Aug; 87(8):1026-31. PubMed ID: 8831209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
    Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
    Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of squamous cell bladder tumors by flow cytometric deoxyribonucleic acid analysis: a report of 100 cases.
    Shaaban AA; Tribukait B; el-Bedeiwy AF; Ghoneim MA
    J Urol; 1990 Oct; 144(4):879-83. PubMed ID: 2398562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of cell kinetic characteristics using flow cytometric measurements of deoxyribonucleic acid and bromodeoxyuridine for bladder cancer.
    Tachibana M; Deguchi N; Jitsukawa S; Baba S; Hata M; Tazaki H
    J Urol; 1991 May; 145(5):963-7. PubMed ID: 2016810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric measurements of deoxyribonucleic acid ploidy and proliferative activity for evaluating malignant potential of human bladder cancers.
    Miyakawa A; Tachibana M; Tazaki H
    Cancer Detect Prev; 1995; 19(2):165-72. PubMed ID: 7750104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative histopathology and deoxyribonucleic acid flow cytometry of random mucosal biopsies in untreated bladder carcinoma.
    Norming U; Nyman CR; Tribukait B
    J Urol; 1991 Jun; 145(6):1164-8. PubMed ID: 2033685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA ploidy pattern of flow cytometry as indicator of malignancy and prognosis in bladder cancer].
    Hosaka Y
    Nihon Rinsho; 1992 Oct; 50(10):2426-31. PubMed ID: 1447813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer.
    Murphy WM; Emerson LD; Chandler RW; Moinuddin SM; Soloway MS
    J Urol; 1986 Oct; 136(4):815-9. PubMed ID: 3761437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.